MENU
VRTX
AS OF
Feb 4, 02:48 PM (EDT)
Price
$473.30
Change
+$7.69 (+1.65%)
Capitalization
118.13B
8 days until earnings call
Intraday BUY SELL Signals
VRTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Vertex Pharmaceuticals (VRTX) Earnings Date & Reports

Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

VRTX is expected to report earnings to rise 5.83% to $5.08 per share on February 12

Vertex Pharmaceuticals VRTX Stock Earnings Reports
Q4'25
Est.
$5.08
Q3'25
Beat
by $0.23
Q2'25
Beat
by $0.25
Q1'25
Missed
by $0.20
Q4'24
Missed
by $0.04
The last earnings report on November 03 showed earnings per share of $4.80, beating the estimate of $4.57. With 129.19K shares outstanding, the current market capitalization sits at 118.13B.
View a ticker or compare two or three
VRTX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. VRTX showed earnings on November 03, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a company that discovers and develops novel, small molecule pharmaceuticals

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
50 Northern Avenue
Phone
+1 617 341-6100
Employees
5400
Web
https://www.vrtx.com